Nad-299 antagonises 5-HT-stimulated and spiperone-inhibited [35S]GTPgammaS binding in cloned 5-HT1A receptors.
Saved in:
| Title: | Nad-299 antagonises 5-HT-stimulated and spiperone-inhibited [35S]GTPgammaS binding in cloned 5-HT1A receptors. |
|---|---|
| Authors: | Jerning E; Department of Lead Discovery, AstraZeneca R&D Södertälje, Novum, Hälsovägen 7, S-141 57 Huddinge, Sweden. eva.jerning@astrazeneca.com, Rosqvist S, Mohell N |
| Source: | Journal of receptor and signal transduction research [J Recept Signal Transduct Res] 2002 Feb-Nov; Vol. 22 (1-4), pp. 483-95. |
| Publication Type: | Comparative Study; Journal Article |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 9509432 Publication Model: Print Cited Medium: Print ISSN: 1079-9893 (Print) Linking ISSN: 10799893 NLM ISO Abbreviation: J Recept Signal Transduct Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1079-9893 |
|---|---|
| DOI: | 10.1081/rrs-120014616 |
